Better Access to Liver Cancer Medicines
#OctoberIs4Livers - Liver Cancer Awareness Month
#OctoberIs4Livers is a global campaign to raise awareness of liver cancer and Hepatitis Queensland is…Read Article
Queenslanders encouraged to check in with their liver
More Queenslanders than ever before are being admitted to hospital due to liver disease with…Read Article
Coronavirus, Hepatitis and Liver Disease
Coronavirus (COVID-19) has received a lot of media coverage in recent weeks and we understand…Read Article
Australians living with liver cancer will soon have new treatment options with changes to the Pharmaceutical Benefits Scheme (PBS) coming into effect.
The changes include better access to treatments for patients with advanced unresectable hepatocellular carcinoma. Unresectable hepatocellular carcinoma is the most common form of liver cancer, which often occurs in people with other chronic liver diseases. It also has one of the lowest survival rates of all cancer types.
From 1 November, more than 500 patients per year could benefit from PBS listing of this treatment, which would otherwise cost more than $170,000 per course. Australia will be the first country in the world to have this combination treatment publically funded for this type of liver cancer.